Variability and quantification of serum medroxyprogesterone acetate levels. [PDF]
Bick AJ +3 more
europepmc +1 more source
Live Birth Outcomes After Extended or Repeated High-Dose Medroxyprogesterone Acetate Therapy for Fertility-Sparing Management of Endometrial Neoplasia: A Single-Center Retrospective Case Series. [PDF]
Yamamura A +9 more
europepmc +1 more source
Editorial Expression of Concern: Cyclic versus continuous medroxyprogesterone acetate for treatment of endometrial hyperplasia without atypia: a 2-year observational study. [PDF]
Emarh M.
europepmc +1 more source
A randomized crossover study to evaluate local tolerability following subcutaneous administration of a new depot medroxyprogesterone acetate contraceptive formulation. [PDF]
Halpern V +6 more
europepmc +1 more source
The effects of oral medroxyprogesterone acetate combined with conjugated equine estrogens on inflammation in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials. [PDF]
Qiu J +5 more
europepmc +1 more source
Depot-medroxyprogesterone acetate: Lipid profile changes and associated cardiovascular risks among acceptors in Sagamu, South West Nigeria. [PDF]
Odelola O, Akadri A.
europepmc +1 more source
Cervical Secretions from Women After Depot Medroxyprogesterone Acetate (Depo-Provera) Administration Promote HIV Infectivity Ex Vivo. [PDF]
Tasker C, Roche NE, Lo Y, Chang TL.
europepmc +1 more source
Update on the Impact of Depot Medroxyprogesterone Acetate on Vaginal Mucosal Endpoints and Relevance to Sexually Transmitted Infections. [PDF]
Dabee S +11 more
europepmc +1 more source
A Rare Case of Splenic Artery Thrombosis Provoked By Medroxyprogesterone Acetate Requiring Splenectomy. [PDF]
Haider AA +7 more
europepmc +1 more source
The Association between Medroxyprogesterone Acetate Exposure and Meningioma. [PDF]
Griffin RL.
europepmc +1 more source

